1. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
   Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
2. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro
   XIANG-QI CHEN et al, 2014, Molecular Medicine Reports CrossRef
3. Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo
   HONG ZHANG et al, 2014, Oncology Reports CrossRef